Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Cross screening panel
Assay data:1 Tested
SummaryRelated BioAssays by Target
Safety47 Scan (DiscoverX - Eurofins)
Dopamine D1 Eurofins Panlabs panel
D1/H Eurofins SafetyScreen44 (BI)
Binding affinity towards human DRD1 in an in vitro assay with cellular components (NIBR assay) measured by scintillation counting
Assay data:18 Active, 13 Activity ≤ 1 µM, 36 Tested
Assay data:35 Active, 19 Activity ≤ 1 µM, 305 Tested
Binding affinity towards human DRD1 in an in vitro assay (CRO assay) measured by scintillation counting
Assay data:6 Active, 104 Tested
Assay data:117 Active, 49 Activity ≤ 1 µM, 927 Tested
Antagonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method
Assay data:21 Active, 8 Activity ≤ 1 µM, 106 Tested
Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method
Assay data:32 Active, 2 Activity ≤ 1 nM, 19 Activity ≤ 1 µM, 1197 Tested
Inhibition of dopamine D1 receptor (unknown origin) upto 10000 nM
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on